|
Nov '04 |
Nov '05 |
Nov '06 |
Nov '07 |
Nov '08 |
 |
|
12 mths |
12 mths |
12 mths |
12 mths |
12 mths |
|
| Net Profit Before Tax |
94.06 |
132.61 |
185.38 |
467.48 |
210.66 |
| Net Cash From Operating Activities |
87.28 |
102.80 |
122.97 |
16.77 |
237.30 |
Net Cash (used in)/from
Investing Activities |
-68.50 |
-73.08 |
-47.99 |
232.53 |
-78.87 |
| Net Cash (used in)/from Financing Activities |
-14.71 |
-46.02 |
-33.82 |
-75.90 |
-95.20 |
| Net (decrease)/increase In Cash and Cash Equivalents |
4.07 |
-16.30 |
41.16 |
173.40 |
63.23 |
| Opening Cash & Cash Equivalents |
22.00 |
26.07 |
9.78 |
306.39 |
479.79 |
| Closing Cash & Cash Equivalents |
26.07 |
9.78 |
50.94 |
479.79 |
543.02 |
|
|
|
|
| Source : Religare Technova |
| Explore Pfizer connections |
|
